15-Keto travoprost is a structurally modified prostaglandin F2ฮฑ derivative featuring a ketone functional group at the 15ฮฒ-position of the cyclopentyl ring, substituting the native hydroxyl moiety. This oxidation product retains the fluorinated pentyl side chain and ฮณ-lactone core characteristic of travoprost, with a trifluoromethylphenyl ester linkage. The compound arises as a synthetic byproduct during API manufacturing or via oxidative degradation pathways. Its distinct carbonyl functionality alters intermolecular interactions, necessitating its quantification as a critical impurity in quality control. Analytically, it serves as a reference standard for HPLC-based impurity profiling in travoprost formulations.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A07920 โ | 10 mg | USD 750.00 |
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/C(=O)COC2=CC=CC(=C2)C(F)(F)F)O)O
InChI=1S/C26H33F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,21-24,31-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t21-,22-,23+,24-/m1/s1
KSDDYCRRTVADFZ-OHDKTVHDSA-N